Syneos Health, Inc. (NASDAQ:SYNH) Q1 2022 Earnings Conference Call April 29, 2022 8:00 AM ET
Company Participants
Ronnie Speight - SVP, IR
Alistair Macdonald - CEO
Michelle Keefe - CEO
Jason Meggs - CFO
Michael Brooks - Chief Operating Officer
Conference Call Participants
Eric Coldwell - Baird
Casey Woodring - JP Morgan
Christine Rains - William Blair
Justin Bowers - Deutsche Bank
David Windley - Jefferies
Sandy Draper - Guggenheim Securities
Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
Operator
00:08 Good morning and welcome to the Syneos Health First Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time.
00:23 I would like to hand the conference over to Ronnie Speight, Senior Vice President of Investor Relations. Please go ahead, sir.
Ronnie Speight
00:39 Good morning, everyone. With me on the call today are Alistair Macdonald, Jason Meggs, Michelle Keefe, and Michael Brooks. In addition to the press release, a slide presentation corresponding to our prepared remarks is available on our website at investor.syneoshealth.com. Remarks that we make about future expectations, growth, trends, anticipated financial results and our expectations regarding the COVID-19 pandemic and the war in Ukraine constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995, and we disclaim any obligation to update them.
01:16 Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors. These factors are discussed in the Risk Factors section of our Form 10-K for the year ended December 31, 2021 and our other SEC filings.
01:34 During this call, we will discuss certain non-GAAP financial measures, which exclude the effects of events and transactions we consider to be outside of our core operations. These non-GAAP measures should be considered a supplement to and not a replacement for measures prepared in accordance with GAAP. For a reconciliation of non-GAAP financial measures with the most directly comparable GAAP measures, please refer to the appendix of our presentation.
02:00 I would now like to turn the call over to Alistair Macdonald. Alistair?